Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China · Delayed Price · Currency is CNY 7.03
+0.01 (0.14%)
At close: Feb 13, 2026
SHE:300289 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -83.31 | -75.1 | 15.34 | -56.27 | 22.42 | -50.98 |
Depreciation & Amortization | 58.5 | 58.5 | 63.03 | 62.91 | 58.94 | 52.17 |
Other Amortization | 8.55 | 8.55 | 7.8 | 5 | 3.05 | 4.48 |
Loss (Gain) From Sale of Assets | - | - | - | -0.45 | -1.34 | 0.93 |
Asset Writedown & Restructuring Costs | 71.13 | 71.13 | 15.11 | 30.69 | 21.72 | 1.89 |
Loss (Gain) From Sale of Investments | -5.93 | -5.93 | -1.77 | -4.13 | -0.07 | -3.42 |
Provision & Write-off of Bad Debts | -0.78 | -0.78 | 11.66 | 26.99 | 4.42 | 74.62 |
Other Operating Activities | -30.86 | -2.05 | 10.13 | 22.26 | 25.5 | 12.75 |
Change in Accounts Receivable | 48.75 | 48.75 | 43.98 | 6.25 | 2.85 | 0.64 |
Change in Inventory | -10.23 | -10.23 | 7.78 | 2.88 | -25.24 | -4.99 |
Change in Accounts Payable | -26.81 | -26.81 | -34.44 | 16.68 | 11.86 | 46.95 |
Operating Cash Flow | 25.4 | 62.41 | 130.8 | 108.93 | 119.06 | 135.56 |
Operating Cash Flow Growth | -59.13% | -52.29% | 20.07% | -8.50% | -12.17% | 8.75% |
Capital Expenditures | -17.17 | -29.23 | -18.69 | -39.12 | -44.5 | -28.39 |
Sale of Property, Plant & Equipment | 0.57 | - | - | 0.59 | 2.14 | 0.05 |
Divestitures | - | - | - | - | - | 5.02 |
Investment in Securities | 217.55 | -17.45 | -338.27 | -178.83 | - | -0.38 |
Other Investing Activities | -1.91 | 7.57 | 3.62 | 4.24 | 0.03 | - |
Investing Cash Flow | 199.03 | -39.11 | -353.33 | -213.11 | -42.33 | -23.7 |
Short-Term Debt Issued | - | - | - | - | - | 39 |
Long-Term Debt Issued | - | - | - | 0.72 | - | - |
Total Debt Issued | - | - | - | 0.72 | - | 39 |
Short-Term Debt Repaid | - | - | - | - | - | -20.33 |
Long-Term Debt Repaid | - | -4.63 | -12.06 | -13.87 | -52.65 | - |
Total Debt Repaid | -4.63 | -4.63 | -12.06 | -13.87 | -52.65 | -20.33 |
Net Debt Issued (Repaid) | -4.63 | -4.63 | -12.06 | -13.15 | -52.65 | 18.67 |
Issuance of Common Stock | - | - | - | - | 550.97 | - |
Common Dividends Paid | - | -5.44 | -0.2 | -10.88 | -0.4 | -7.52 |
Other Financing Activities | 0.8 | -6.4 | 1.5 | -0.73 | 1.23 | -56.9 |
Financing Cash Flow | -3.83 | -16.47 | -10.76 | -24.76 | 499.15 | -45.74 |
Foreign Exchange Rate Adjustments | -0.29 | -0.3 | -0.49 | -0.13 | 0.17 | - |
Net Cash Flow | 220.31 | 6.53 | -233.79 | -129.07 | 576.04 | 66.11 |
Free Cash Flow | 8.23 | 33.18 | 112.11 | 69.81 | 74.56 | 107.17 |
Free Cash Flow Growth | -78.05% | -70.40% | 60.58% | -6.36% | -30.43% | 8.94% |
Free Cash Flow Margin | 2.42% | 8.96% | 24.29% | 9.89% | 13.22% | 22.73% |
Free Cash Flow Per Share | 0.01 | 0.06 | 0.21 | 0.12 | 0.17 | 0.25 |
Cash Income Tax Paid | 34.74 | 43.48 | 61.42 | 60.55 | 60.69 | 52.82 |
Levered Free Cash Flow | 125 | 23.88 | 78.37 | 51.4 | 94.9 | 132.45 |
Unlevered Free Cash Flow | 125.13 | 24.07 | 78.78 | 52.21 | 96.24 | 134.05 |
Change in Working Capital | 8.08 | 8.08 | 9.51 | 21.95 | -15.57 | 43.12 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.